AAAAAA

   
Results: 1-11 |
Results: 11
The potential of CpG oligodeoxynucleotides as mucosal adjuvants
Authors: McCluskie, MJ Weeratna, RD Payette, PJ Davis, HL
Citation: Mj. Mccluskie et al., The potential of CpG oligodeoxynucleotides as mucosal adjuvants, CR R IMMUN, 21(1-3), 2001, pp. 103-120
Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms
Authors: Payette, PJ Weeratna, RD McCluskie, MJ Davis, HL
Citation: Pj. Payette et al., Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms, GENE THER, 8(18), 2001, pp. 1395-1400
Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies
Authors: Weeratna, RD Millan, CLB McCluskie, MJ Siegrist, CA Davis, HL
Citation: Rd. Weeratna et al., Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies, FEMS IM MED, 30(3), 2001, pp. 241-247
Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants
Authors: McCluskie, MJ Weeratna, RD Clements, JD Davis, HL
Citation: Mj. Mccluskie et al., Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants, VACCINE, 19(27), 2001, pp. 3759-3768
The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants
Authors: McCluskie, MJ Weeratna, RD Davis, HL
Citation: Mj. Mccluskie et al., The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants, VACCINE, 19(17-19), 2001, pp. 2657-2660
Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigendistribution
Authors: McCluskie, MJ Weeratna, RD Davis, HL
Citation: Mj. Mccluskie et al., Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigendistribution, MOL MED, 6(10), 2000, pp. 867-877
The role of CpG in DNA vaccines
Authors: McCluskie, MJ Weeratna, RD Davis, HL
Citation: Mj. Mccluskie et al., The role of CpG in DNA vaccines, SPR SEM IMM, 22(1-2), 2000, pp. 125-132
Optimization strategies for DNA vaccines
Authors: Weeratna, RD McCluskie, MJ Comanita, L Wu, T Davis, HL
Citation: Rd. Weeratna et al., Optimization strategies for DNA vaccines, INTERVIROLO, 43(4-6), 2000, pp. 218-226
CpG DNA is an effective oral adjuvant to protein antigens in mice
Authors: McCluskie, MJ Weeratna, RD Krieg, AM Davis, HL
Citation: Mj. Mccluskie et al., CpG DNA is an effective oral adjuvant to protein antigens in mice, VACCINE, 19(7-8), 2000, pp. 950-957
CpG DNA induces stronger immune responses with less toxicity than other adjuvants
Authors: Weeratna, RD McCluskie, MJ Xu, Y Davis, HL
Citation: Rd. Weeratna et al., CpG DNA induces stronger immune responses with less toxicity than other adjuvants, VACCINE, 18(17), 2000, pp. 1755-1762
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
Authors: Hartmann, G Weeratna, RD Ballas, ZK Payette, P Blackwell, S Suparto, I Rasmussen, WL Waldschmidt, M Sajuthi, D Purcell, RH Davis, HL Krieg, AM
Citation: G. Hartmann et al., Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo, J IMMUNOL, 164(3), 2000, pp. 1617-1624
Risultati: 1-11 |